Translate Bio Reports Q1 Revenues Of $1.4M Reports Q1 Net Loss Of $33.2M Vs. A Net Loss Of $21.2M In The Prior Year; Completed Dosing In Single-Ascending Dose Portion Of Phase 1/2 Clinical Trial In Cystic Fibrosis; Data Expected 3Q19